http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004091507-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb44af5db125eb6b0781af540ac7257a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2fdfdb4cb450625500a90f393ff7552
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2004-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51e96308a59d763c9e1c867f3e76a925
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf1fb0bb89944a8896428aeec5300439
publicationDate 2004-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004091507-A2
titleOfInvention Optimal polyvalent vaccine for cancer
abstract This invention also provides a method for identification of the optimal combination of a polyvalent vaccine against a cancer comprising steps of: a) selection of an appropriate cancer cell line; and b) detection of the expression of antigens on the surface of said cell line of the cancer, wherein the antigens expressed will be used in the polyvalent vaccine. This invention also provides a method for identification of the optimal combination of a polyvalent vaccine against a cancer comprising steps of: a) selection of an appropriate cancer cell line and b) detection of the immunogenicity will be used in the polyvalent vaccine. This invention provides various uses of the identified polyvalent vaccine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9572875-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383118-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463724-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8540964-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8092780-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1941278-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1941278-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884098-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9149516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547749-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9631025-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9138475-B2
priorityDate 2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18729306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129854253
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12509
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397347
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426274922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128897558
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID567192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11744779
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID518609
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426284160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45259178
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394044
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID419852
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11029734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456490786
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64036

Total number of triples: 53.